Evogene Selects Acute Graft-Versus-Host Disease as Target for AI-Driven Drug Discovery

Filing content

Evogene announced acute graft-versus-host disease (aGVHD) as the target indication for its AI-driven drug discovery program and is advancing lead candidates toward IND-enabling studies.